Severe forms of neurocysticercosis: Treatment with albeimdazole

Arquivos de Neuro-Psiquiatria

Volumn 54, Issue 1, 1996, Pages 82-93

  Agapejev, Svetlana ^a   Da Silva, Maria Dorvalina ^a   Ueda, Anete K ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Albendazole; Cysticercosis; Dextrochloropheniramine; Ketoprofen; Neurocysticercosis; Severe forms; Treatment

Indexed keywords

ACETAZOLAMIDE; ALBENDAZOLE; DEXCHLORPHENIRAMINE; KETOPROFEN; MANNITOL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEUROCYSTICERCOSIS;

EID: 0029965675     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X1996000100014     Document Type: Article

References (34)

1. Agapejev S, Meira DA, Barraviera B, Machado JM, Pereira PCM, Kamegasawa A, Ueda AK Neurocysticercosis: treatment with albendazole and dextrochloropheniramine. Trans R Soc Trop Med Hyg 1989; 83:377-383.
2. Agapejev S. Incidence of neurocysticercosis at the University Hospital, Faculty of Medicine of Botucatu, State University of São Paulo (Abstract). Thesis, Rsbeirão Preto, 1994. Arq Neuropsiquiatr 1995; 53: 170-171.
3. o. Albendazol em neurocisticercose: relato de 5 casos. Rev Bras Neurol 1991; 27:115-120
4. Araújo LP, Silva MN. Formas císticas da neurocisticercose: consideraçoes sobre o tratamento cirúrgico. Arq Bras Neurocirurg 1994, 13:173-180.
5. Camargo-Lima JG. Cisticercose encefálica: aspectos clínicos. Thesis, Escola Paulista de Medicina São Paulo, 1966.
6. Colli BO, Martelli N, Assirati JA Jr, Machado HR, Salvarini CP, Sassoli VP, Forjaz SV. Cysticercosis of the central nervous system. I Surgical treatment of cerebral cysticercosis - a 23 years experience in the Hospital das Clínicas of Ribeirão Preto Medical School. Arq Neuropsiquiatr 1994; 52:166-186.
7. Correa D, Dalma D, Espinoza B, Plancarte A, Rabiela MT, Madrazo I, Gorodezky C, Flisser A. Heterogeneity of humoral immune components in human cysticercosis. J Parasitol 1985; 71: 535-541.
8. Cruz M, Cruz I, Horton J. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation. Trans R Soc Trop Med Hyg 1991, 85:244-247.
9. Davis LE, Kornfeld M Neurocysticercosis: neurologic, pathogenic, diagnosis and therapeutic aspects. Eur Neurol 1991; 31:229-240.
10. Del Brutto OH, Sotelo J. Neurocysticercosis:an update. Rev Infect Dis 1988, 10:1075-1087.
11. Del Brutto OH, Sotelo J. Albendazole therapy for subarachnoid and ventricular cysticercosis. J Neurosurg 1990; 72:816-817.
12. Del Brutto OH, Sotelo J, Aguirre R, Díaz-Calderón E, Alarcón JA . Albendazole therapy for giant subarachnoid cysticerci. Arch Neurol 1992; 49.535-538.
13. Escobedo F, Penagos P, Rodriguez J, Sotelo J. Eficacia de albendazol en el tratamiento médico de la cisticercosis cerebral: estudio controlado tomográficamente. Invest Méd Internat 1988, 15(Supl): 23-26.
14. Estañol B, Corona T, Abad P. A prognostic classification of cerebral cysticercosis , therapeutic implications. J Neurol Neurosurg Psychiatry 1986; 49:1131-1134.
15. Flisser A, Perez-Monfort R, Larralde C. The immunology of human and animal cysticercosis : a review. Bull WHO 1979, 57:839-856.
16. Gilman AG, Goodman LS, Rall RW, Murad F. The pharmacological basis of therapeutics.Ed 7. New York: Macmillan 1980: 627-629.
17. Jung H, Hurtado M, Sanchez M, Medina MT, Sotelo J. Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. Cl Neuropharmacol 1990; 13:559-564.
18. Livramento JA, Machado LR, Spina-França A. Immunology of neurocysticercosis. In Fejerman N, Chamoles NA (eds). New trends in pediatrics neurology Amsterdam: Elsevier, 1993; 307-312.
19. Lobato R, Lamas E, Portillo JM, Roger R, Esparza J, Rivas JJ, Muñoz MJ. Hydrocephalus in cerebral cysticercosis: pathogenic and therapeutic considerations. J Neurosurg 1981; 55.786-793.
20. Malagón F. Elementos del binoìnio taeniasis/cisticercosis: una sintesis. In Flisser A, Malagón F (eds). Cisticercosis humana y porcina: su conocimiento e investigación en México. Ciudad de Mèxico: Limusa, 1989: 3-6
21. Moreira EL. Neurocisticercose. Clínica, patologia e tratamento da forma ventricular bloqueante. Thesis,. Faculdade de Medicina de Ribeirão Preto. Ribeirão Preto, 1984.
22. Miller O. Curso de corticoterapia. J Bras Med 1978. (ed esp): 7-11.
23. Netter P, Lapique F, Bannwarth B, Tamisier JN, Thomas P, Royer RJ. Diffusion of intramuscular ketoprofen into the cerebrospinal fluid. Eur J Clin Pharmacol 1985; 29:319-321.
24. Salazar A, Sotelo J, Martinez H, Escobedo F. Differential diagnosis between ventriculitis and fourth ventricle cyst in neurocysticercosis. J Neurosurg 1983; 59:660-663.
25. Sotelo J, Marin C. Hydrocephalus secondary to cysticercotic arachnoiditis, a long-term follow-up review. J Neurosurg 1987; 66:686-689.
26. Sotelo J, Escobedo F, Penagos P. Albendazole vs praziquantel for therapy for neurocysticercosis: a controlled trial. Arch Neurol 1988: 45:532-534.
27. Sotelo J, Del Brutto OH, Penagos P, Torres B, Rodriguez-Carbajal J, Rubio-Donnadieu F. Comparison of therapeutic regimen of anti-cysternal drugs for parenchymal brain cysticercosis. J Neurol 1990; 237:69-72.
28. Spina-França A. Síndrome liquórica da neurocisticercose. Arq Neuropsiquiatr 1961; 19:307-314.
29. Spina França A. Cysticercosis of the central nervous system. In Chopra JS et al (eds). Advances in neurology Amsterdam Elsevier, 1990: 283-291
30. Stepien L, Choróbski J Cysticercosis cerebrì and its operative treatment. Arch Neurol Psychiat 1949; 61:499-527.
31. Takayanagui OM, Jardim E. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Arch Neurol 1992; 49:290-294.
32. Torrealba G, Del Villar S, Tagle P, Arriagada P, Kase CS Cysticercosis of the central nervous system-clinical and therapeutic considerations. J Neurol Neurosurg Psychiatry 1984; 47:784-790.
33. Vasconcelos D, Cruz-Segura H, Mateos-Gomez H, Zenteno-Alanis G. Selective indications for the use of praziquantel in the treatment of brain cysticercosis. J Neurol Neurosurg Psychiatry 1987; 50:383-388.
34. Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis N Engl J Med 1992; 327: 696-701.